Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Dose Range Finding Study of Fedovapagon in Men With Nocturia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Vantia Ltd
ClinicalTrials.gov Identifier:
NCT01656239
First received: July 31, 2012
Last updated: June 18, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 18, 2014